vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $23.6M, roughly 1.6× GENCOR INDUSTRIES INC). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -3.7%, a 18.3% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -25.0%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
GENC vs GYRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $37.2M |
| Net Profit | $3.4M | $-1.4M |
| Gross Margin | 28.7% | 95.3% |
| Operating Margin | 13.2% | 0.3% |
| Net Margin | 14.6% | -3.7% |
| Revenue YoY | -25.0% | 33.4% |
| Net Profit YoY | -9.8% | -340.1% |
| EPS (diluted) | $0.23 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $37.2M | ||
| Q3 25 | $18.8M | $30.6M | ||
| Q2 25 | $27.0M | $26.8M | ||
| Q1 25 | $38.2M | $22.1M | ||
| Q4 24 | $31.4M | $27.9M | ||
| Q3 24 | $20.9M | $25.5M | ||
| Q2 24 | $25.6M | $25.2M | ||
| Q1 24 | $40.7M | $27.2M |
| Q4 25 | $3.4M | $-1.4M | ||
| Q3 25 | $1.9M | $5.9M | ||
| Q2 25 | $3.8M | $1.6M | ||
| Q1 25 | $6.1M | $3.7M | ||
| Q4 24 | $3.8M | $569.0K | ||
| Q3 24 | $1.5M | $2.9M | ||
| Q2 24 | $2.6M | $4.5M | ||
| Q1 24 | $6.2M | $9.9M |
| Q4 25 | 28.7% | 95.3% | ||
| Q3 25 | 24.2% | 94.7% | ||
| Q2 25 | 26.5% | 95.7% | ||
| Q1 25 | 29.7% | 95.9% | ||
| Q4 24 | 27.6% | 95.8% | ||
| Q3 24 | 25.6% | 96.2% | ||
| Q2 24 | 23.9% | 96.9% | ||
| Q1 24 | 30.3% | 96.4% |
| Q4 25 | 13.2% | 0.3% | ||
| Q3 25 | -1.2% | 22.7% | ||
| Q2 25 | 11.6% | 8.1% | ||
| Q1 25 | 17.0% | 10.3% | ||
| Q4 24 | 14.7% | 2.4% | ||
| Q3 24 | 5.9% | 16.6% | ||
| Q2 24 | 7.8% | 12.7% | ||
| Q1 24 | 17.4% | 29.7% |
| Q4 25 | 14.6% | -3.7% | ||
| Q3 25 | 10.2% | 19.4% | ||
| Q2 25 | 14.2% | 5.9% | ||
| Q1 25 | 16.0% | 16.9% | ||
| Q4 24 | 12.1% | 2.0% | ||
| Q3 24 | 6.9% | 11.2% | ||
| Q2 24 | 10.0% | 18.0% | ||
| Q1 24 | 15.3% | 36.6% |
| Q4 25 | $0.23 | $-0.01 | ||
| Q3 25 | $0.13 | $0.03 | ||
| Q2 25 | $0.26 | $0.00 | ||
| Q1 25 | $0.42 | $0.00 | ||
| Q4 24 | $0.26 | $0.00 | ||
| Q3 24 | $0.10 | $0.01 | ||
| Q2 24 | $0.17 | $0.01 | ||
| Q1 24 | $0.42 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $52.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $106.0M |
| Total Assets | $228.9M | $166.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | $52.4M | ||
| Q3 25 | $136.3M | $60.0M | ||
| Q2 25 | $136.0M | $54.4M | ||
| Q1 25 | $143.7M | $29.9M | ||
| Q4 24 | $130.1M | $26.7M | ||
| Q3 24 | $115.4M | $25.1M | ||
| Q2 24 | $116.6M | $25.1M | ||
| Q1 24 | $117.1M | $37.4M |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | $106.0M | ||
| Q3 25 | $211.8M | $101.9M | ||
| Q2 25 | $209.9M | $92.0M | ||
| Q1 25 | $206.1M | $68.1M | ||
| Q4 24 | $200.0M | $63.3M | ||
| Q3 24 | $196.1M | $63.2M | ||
| Q2 24 | $194.7M | $60.4M | ||
| Q1 24 | $192.1M | $56.6M |
| Q4 25 | $228.9M | $166.1M | ||
| Q3 25 | $222.6M | $159.4M | ||
| Q2 25 | $220.2M | $152.6M | ||
| Q1 25 | $223.9M | $129.8M | ||
| Q4 24 | $218.2M | $125.4M | ||
| Q3 24 | $208.1M | $125.2M | ||
| Q2 24 | $201.8M | $120.9M | ||
| Q1 24 | $206.0M | $122.0M |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $-5.6M |
| Free Cash FlowOCF − Capex | $10.1M | $-5.8M |
| FCF MarginFCF / Revenue | 43.0% | -15.5% |
| Capex IntensityCapex / Revenue | 4.1% | 0.4% |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | $-5.6M | ||
| Q3 25 | $-275.0K | $4.7M | ||
| Q2 25 | $-23.9M | $2.1M | ||
| Q1 25 | $12.4M | $-129.0K | ||
| Q4 24 | $14.8M | $-2.8M | ||
| Q3 24 | $-3.2M | $1.7M | ||
| Q2 24 | $-1.0M | $-5.5M | ||
| Q1 24 | $11.7M | $2.9M |
| Q4 25 | $10.1M | $-5.8M | ||
| Q3 25 | $-1.3M | $4.0M | ||
| Q2 25 | $-24.4M | $1.8M | ||
| Q1 25 | $12.3M | $-251.0K | ||
| Q4 24 | $14.5M | $-2.8M | ||
| Q3 24 | $-3.3M | $1.0M | ||
| Q2 24 | $-1.4M | $-6.9M | ||
| Q1 24 | $11.7M | $2.7M |
| Q4 25 | 43.0% | -15.5% | ||
| Q3 25 | -6.8% | 13.1% | ||
| Q2 25 | -90.4% | 6.8% | ||
| Q1 25 | 32.2% | -1.1% | ||
| Q4 24 | 46.1% | -10.1% | ||
| Q3 24 | -15.8% | 4.1% | ||
| Q2 24 | -5.6% | -27.5% | ||
| Q1 24 | 28.7% | 9.8% |
| Q4 25 | 4.1% | 0.4% | ||
| Q3 25 | 5.4% | 2.2% | ||
| Q2 25 | 1.8% | 1.0% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 1.0% | 0.2% | ||
| Q3 24 | 0.4% | 2.7% | ||
| Q2 24 | 1.5% | 5.8% | ||
| Q1 24 | 0.0% | 0.9% |
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | 0.79× | ||
| Q2 25 | -6.24× | 1.32× | ||
| Q1 25 | 2.04× | -0.03× | ||
| Q4 24 | 3.88× | -4.85× | ||
| Q3 24 | -2.22× | 0.60× | ||
| Q2 24 | -0.41× | -1.21× | ||
| Q1 24 | 1.87× | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
